Loss of PKN2 drives fibroblast reprogramming and extracellular matrix remodelling in pulmonary fibrosis

The lungs are designed to be soft, spongy, and full of tiny air sacs that allow oxygen to pass into the blood. In a healthy body, when these tissues are injured, specialized cells called fibroblasts rush to the site to lay down a temporary scaffold of proteins, helping the wound heal and the tissue return to normal. However, in a devastating condition known as idiopathic pulmonary fibrosis, this repair process goes wrong. Instead of healing and stopping, the fibroblasts become overactive, laying down thick, stiff layers of scar tissue that replace the delicate air sacs. This scarring makes the lungs rigid and unable to expand, slowly suffocating the patient. While doctors have treatments that can slow this progression, they cannot reverse the damage once it has occurred, and the underlying reasons why these cells lose control remain a mystery.

A team of researchers has now uncovered a missing piece of this puzzle, identifying a specific protein that acts as a brake on this destructive process. This protein, known as PKN2, is normally present in lung cells, but the study found that it disappears in the lungs of people with fibrosis. When the researchers removed this protein from healthy lung cells in the laboratory, the cells immediately began to behave like the diseased ones: they started producing excessive amounts of the sticky proteins that form scars and began to migrate and repair wounds much faster than they should. The findings suggest that the loss of this single protein is a key driver that pushes lung cells into a state of uncontrolled repair, leading to the formation of the fibrotic tissue that destroys lung function.

To understand how this happens, the scientists first looked at actual lung tissue from patients with the disease and compared it to tissue from healthy donors. They found that the healthy lungs were rich in the PKN2 protein, which was spread throughout the airways and the deep lung tissue. In contrast, the fibrotic lungs showed a significant drop in the amount of this protein. The researchers also examined cells grown in a dish, isolating fibroblasts from both healthy people and patients with the disease. In every case, the cells taken from patients had much lower levels of PKN2 than the healthy cells. Furthermore, when they exposed healthy cells to a chemical signal known to trigger fibrosis, the level of this protective protein dropped even further, suggesting that the disease process actively suppresses it.

The team then investigated why the protein was missing. They discovered that the DNA instructions for making PKN2 were chemically altered in the cells from patients. These chemical changes, known as DNA methylation, act like a switch that can turn genes off. In the fibrotic cells, the switch for PKN2 was flipped to the off position more often than in healthy cells. When the researchers used a drug to block the chemical machinery responsible for these switches, the cells began to make the protein again, confirming that this chemical modification was a primary reason for the protein's disappearance.

With the cause of the loss identified, the researchers wanted to see what happened when they deliberately removed the protein from healthy cells. They used a technique to silence the gene that produces PKN2, effectively deleting it from the cells. The results were immediate and dramatic. Without this protein, the cells underwent a complete transformation. They began to produce far more of the structural proteins that build scar tissue, such as collagen, and they started secreting signals that encourage blood vessel growth and further tissue remodeling. The cells also became more aggressive in their movement; when the researchers scratched a small gap in a layer of these cells to mimic a wound, the cells without PKN2 rushed to close the gap much faster than the control cells. This rapid closure, combined with the overproduction of scar-building materials, mirrors the chaotic repair process seen in the human lung.

To ensure these changes were not just a laboratory artifact, the team looked at the cells' internal machinery using advanced imaging and chemical analysis. They found that the loss of PKN2 triggered a cascade of changes in the cell's genetic instructions and its protein-making factories. The cells turned on genes associated with building scar tissue and turned off genes that normally keep repair in check. This shift was not random; it involved a coordinated network of signals that the cells use to communicate and organize their structure. The researchers also tested this in a living system using zebrafish larvae, which are transparent and allow scientists to watch healing in real time. When they treated the fish with a drug that blocked PKN signaling, the fish's wounds healed differently. The skin cells that should have lined up neatly to cover the wound became disorganized, and the collagen fibers that form the structural support of the skin failed to align properly. This confirmed that the protein is essential for organizing the repair process correctly, not just for speeding it up.

The study also connected these findings to a broader genetic picture. Previous large-scale studies of human DNA had already hinted that variations in the PKN2 gene were linked to how quickly lung function declined in patients with fibrosis. This new work explains why that link exists: the loss of PKN2 is not just a marker of the disease, but a direct cause of the cellular chaos that drives it. The researchers noted that while this protein acts as a protector in the lungs, its role in other parts of the body, such as the heart, might be different, suggesting that any future treatment would need to be carefully targeted to avoid unintended side effects.

Ultimately, this research paints a clear picture of a biological failure. The lung's ability to heal is governed by a delicate balance, and PKN2 is a critical component that keeps that balance in check. When this protein is lost, the brakes fail, and the repair mechanism runs wild, turning a healing response into a destructive one. By identifying this specific protein and the chemical switches that control it, the study provides a new map for understanding how fibrosis starts and offers a potential target for future therapies. The goal would be to find a way to restore the levels of this protein or mimic its function, helping the lung cells to stop overproducing scar tissue and return to a state of healthy repair.